Centro de Documentacion de Fundación MAPFRE - Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges

MAP20240010898

Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges. — London : Willis Towers Watson, 2024

24 p.

Documento relacionado: Global life sciences risk outlook 2023. Managing emerging risks, challenges and opportunities in the life science sector : WTW global life science survey. - London : Willis Towers Watson, 2022

Sumario: The life science sector has experienced rapid evolution in recent years, driven by scientific breakthroughs in areas such as gene and cell therapies, biologics and new vaccines. However, this swift progress has also brought challenges. Some innovations have not lived up to their initial promise, and concerns about the high costs of drug development have grown. Additionally, companies are struggling to find individuals with the specialized skills they need. In our second Life Science global survey, we asked 400 senior decision-makers about their perspectives on this changing landscape. We explored their views on the main risks and opportunities, how they are managing emerging challenges, and their plans for the future. — Ámbito geográfico: Internacional

1. Ciencias de la salud . 2. Gerencia de riesgos . 3. Riesgos emergentes . 4. Transformación digital . 5. Innovación empresarial . 6. Tendencias . 7. Factores de riesgo . 8. Encuestas . I. Willis Towers Watson . II. Título.